Rainbow Coral Corp. (OTCQB: RBCC) believes lawmakers and politicians have lost sight of a drug that far too often leads users to abuse and addiction, and unlike substances candidates and activists rail against, this one is perfectly legal.

“The true gateway drug is not some illicit powder or plant,” said RBCC CEO Kimberly Palmer. “Important new research is revealing alcohol is the drug that eventually sets a number of people on the path to greater, harder and often illegal drug use. We’re certainly not against responsible alcohol use. However, word needs to spread that alcohol abuse and addiction are where the path to further pain and suffering begins. This is the driving force behind our plans to develop low-cost treatment centers for alcohol abuse and addiction.”

Researchers from Texas A&M University and the University of Florida surveyed nearly 3,000 U.S. 12th graders and data showed the majority of those who said they had used illegal drugs first tried alcohol before marijuana or tobacco. More than 50 percent said alcohol was their initial gateway versus just 14 percent who responded marijuana.

“The results are clear,” Palmer said. “The earlier one tries alcohol, the greater the chance of future illicit drug use. So our national focus is all wrong. Our government is concentrating on the wrong substance. We’re working hard to change that and to develop real, affordable solutions.”

Through its biotech subsidiary, Rainbow Biosciences, RBCC markets and develops new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc. (BIIB), Abbott Laboratories (ABT) and Amgen Inc. (AMGN).

For more information on RBCC’s initiatives, please visit www.rainbowbiosciences.com.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.